Correlation Between Bioventus and Doximity
Can any of the company-specific risk be diversified away by investing in both Bioventus and Doximity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioventus and Doximity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioventus and Doximity, you can compare the effects of market volatilities on Bioventus and Doximity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioventus with a short position of Doximity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioventus and Doximity.
Diversification Opportunities for Bioventus and Doximity
Very good diversification
The 3 months correlation between Bioventus and Doximity is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Bioventus and Doximity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Doximity and Bioventus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioventus are associated (or correlated) with Doximity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Doximity has no effect on the direction of Bioventus i.e., Bioventus and Doximity go up and down completely randomly.
Pair Corralation between Bioventus and Doximity
Considering the 90-day investment horizon Bioventus is expected to under-perform the Doximity. But the stock apears to be less risky and, when comparing its historical volatility, Bioventus is 1.36 times less risky than Doximity. The stock trades about -0.02 of its potential returns per unit of risk. The Doximity is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 4,349 in Doximity on November 1, 2024 and sell it today you would earn a total of 1,418 from holding Doximity or generate 32.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bioventus vs. Doximity
Performance |
| Timeline |
| Bioventus |
| Doximity |
Bioventus and Doximity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bioventus and Doximity
The main advantage of trading using opposite Bioventus and Doximity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioventus position performs unexpectedly, Doximity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Doximity will offset losses from the drop in Doximity's long position.| Bioventus vs. Tivic Health Systems | Bioventus vs. Bluejay Diagnostics | Bioventus vs. Heart Test Laboratories | Bioventus vs. Nuwellis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |